Assignee
INNOVATIVE CELLULAR THERAPEUTICS CO LTD
CN·11 granted patents·4 pending applications·57 citations·filing 2016–2019
Top patents by PatentIndex Score
15 records- 0195US10869888B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Dec 22, 2020·10 cites·28 claims
- 0295US10561686B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Feb 18, 2020·17 cites·9 claims
- 0395US9932405B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2017·Granted Apr 3, 2018·13 cites·8 claims
- 0494US10493139B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Dec 3, 2019·9 cites·5 claims
- 0589US10865382B2Reducing immune tolerance induced by PD-L1INNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Dec 15, 2020·2 cites·20 claims
- 0688US10793638B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted Oct 6, 2020·2 cites·15 claims
- 0787US10918667B2Modified cell expressing therapeutic agent and uses thereofINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Feb 16, 2021·2 cites·14 claims
- 0886US10619136B2Reducing immune tolerance induced by PD-L1INNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2016·Granted Apr 14, 2020·2 cites·27 claims
- 0968US11981920B2Modified cell with enhanced migration capabilityINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted May 14, 2024·0 cites·15 claims
- 1059US10654934B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Granted May 19, 2020·0 cites·33 claims
- 1157US11866494B2CAR T therapy through uses of co-stimulationINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Granted Jan 9, 2024·0 cites·9 claims
- 1254US2021379149A1Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 1351US2017218380A1Method for directional cloningINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2017·Application pending·0 cites
- 1446US2018223255A1Activation and Expansion of T CellsINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2018·Application pending·0 cites
- 1542US2018327716A9Modified cells for production of blood cellsINNOVATIVE CELLULAR THERAPEUTICS CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INNOVATIVE CELLULAR THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →